Skip to main content
Tech.euFundingExplorerBeta

Eli Lilly

Investor profile

Venture capital

Eli Lilly has backed 2 European tech companies across 2 funding rounds between 2024 and 2025, joining rounds totalling €102M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
2
distinct rounds
Companies
2
backed
Active span
2024–2025
2 yrs
Total round €
€102M
sum of rounds joined

Deals by year

distinct rounds / year
Eli Lilly — deals by year — interactive chart.
Data table
Eli Lilly — deals by year
20241
20251

Top sectors

by deals
Eli Lilly — top sectors — interactive chart.
Data table
Eli Lilly — top sectors
Healthtech2

Stages

by deals
Eli Lilly — stages — interactive chart.
Data table
Eli Lilly — stages
Other1
Series A1

Countries

by deals
Eli Lilly — countries — interactive chart.
Data table
Eli Lilly — countries
Denmark1
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Eli Lilly — 2 dealsEli LillyBGF — 1 shared deals · click to openBGFCormorant — 1 shared deals · click to openCormorantExport and Investment Fund of Denmark (EIFO) — 1 shared deals · click to openExport and Investment Fund of Denmark (EIFO)Forbion — 1 shared deals · click to openForbionIQ Capital — 1 shared deals · click to openIQ CapitalM Ventures — 1 shared deals · click to openM VenturesMeltwind — 1 shared deals · click to openMeltwindNEA (New Enterprise Associates) — 1 shared deals · click to openNEA (New Enterprise Associates)Novo Holdings — 1 shared deals · click to openNovo HoldingsOctopus Ventures — 1 shared deals · click to openOctopus Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Orbis MedicinesDenmark1€90M
NanoSyrinxUK1€12M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Orbis MedicinesSeries A€90M2025-01
NanoSyrinxOther€12M2024-09
← Back to investors